Resmed (RMD) Accounts Payables (2010 - 2026)

Resmed's Accounts Payables history runs 17 years deep, the most recent figure standing at $273.3 million for Q1 2026.

• Quarterly Accounts Payables rose 22.8% year-over-year to $273.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $273.3 million (up 22.8% YoY) and the FY2025 annual result came in at $278.2 million, up 17.01% from the prior year.
• Accounts Payables was $273.3 million for Q1 2026 at Resmed, up from $250.4 million in the prior quarter.
• Across five years, Accounts Payables topped out at $278.2 million in Q2 2025 and bottomed at $149.8 million in Q1 2022.
• A 5-year average of $209.1 million and a median of $202.4 million in 2023 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2023 — Accounts Payables decreased 5.33% — and 2024, when it soared 57.69%.
• Resmed's Accounts Payables stood at $196.0 million in 2022, then climbed by 3.26% to $202.4 million in 2023, then increased by 8.85% to $220.3 million in 2024, then climbed by 13.66% to $250.4 million in 2025, then grew by 9.14% to $273.3 million in 2026.
• Business Quant data shows RMD's Accounts Payables at $273.3 million in Q1 2026, $250.4 million in Q4 2025, and $266.8 million in Q3 2025.